| Literature DB >> 27474339 |
Nancy Luo1, Joseph G Rogers2, Gwen C Dodson3, Chetan B Patel2, Anthony N Galanos3, Carmelo A Milano4, Christopher M O'Connor5, Robert J Mentz2.
Abstract
Within the last decade, advancements in left ventricular assist device therapy have allowed patients with end-stage heart failure (HF) to live longer and with better quality of life. Like other life-saving interventions, however, there remains the risk of complications including infections, bleeding episodes, and stroke. The candidate for left ventricular assist device therapy faces complex challenges going forward, both physical and psychological, many of which may benefit from the application of palliative care principles by trained specialists. Despite these advantages, palliative care remains underused in many advanced HF programs. Here, we describe the benefits of palliative care, barriers to use within HF, and specific applications to the integrated care of patients on mechanical circulatory support.Entities:
Mesh:
Year: 2016 PMID: 27474339 PMCID: PMC4988910 DOI: 10.1016/j.amjcard.2016.06.010
Source DB: PubMed Journal: Am J Cardiol ISSN: 0002-9149 Impact factor: 2.778